Inventor · disambiguated record
Adrian Rice
Also filed as: RICE ADRIAN · RICE ADRIAN E
12 granted patents·8 pending applications·17 citations·filing 2016–2025
85Inventor score
Top patents by PatentIndex Score
20 records- 0191US11104916B2Compositions and methods for alphavirus vaccinationETUBICS CORP·Filed 2017·Granted Aug 31, 2021·6 cites·17 claims
- 0287US11304998B2Combination immunotherapies comprising IL-15 superagonistsETUBICS CORP·Filed 2021·Granted Apr 19, 2022·1 cites·9 claims
- 0383US11149087B2Methods and compositions for combination immunotherapyETUBICS CORP·Filed 2016·Granted Oct 19, 2021·2 cites·25 claims
- 0481US12290558B2SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogensIMMUNITYBIO INC·Filed 2023·Granted May 6, 2025·0 cites·11 claims
- 0581US11020467B2Combination immunotherapies comprising IL-15 superagonistsETUBICS CORP·Filed 2018·Granted Jun 1, 2021·1 cites·10 claims
- 0679US10835596B2Compositions and methods for flavivirus vaccinationETUBICS CORP·Filed 2017·Granted Nov 17, 2020·2 cites·16 claims
- 0777US12487241B2Rapid verification of virus particle production for a personalized vaccineNANTCELL INC·Filed 2022·Granted Dec 2, 2025·0 cites·13 claims
- 0876US11022406B2Inconspicuous defense substance spray canisterRICE ADRIAN·Filed 2019·Granted Jun 1, 2021·4 cites·11 claims
- 0969US2025235530A1Anti COVID-19 Therapies targeting nucleocapsid and spike proteinsIMMUNITYBIO INC·Filed 2025·Application pending·0 cites
- 1068US11857620B2Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirusIMMUNITYBIO INC·Filed 2021·Granted Jan 2, 2024·0 cites·11 claims
- 1167US11573230B2Rapid verification of virus particle production for a personalized vaccineNANTCELL INC·Filed 2019·Granted Feb 7, 2023·0 cites·12 claims
- 1267US2021138056A1Neoepitope vaccine compositions and methods of use thereofETUBICS CORP·Filed 2021·Application pending·0 cites
- 1364US11352642B2Methods and compositions for combination immunotherapyETUBICS CORP·Filed 2016·Granted Jun 7, 2022·1 cites·14 claims
- 1458US2020282032A1Neoepitope vaccine compositions and methods of use thereofETUBICS CORP·Filed 2017·Application pending·0 cites
- 1555US12285480B2Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenovirusesNANTCELL INC·Filed 2021·Granted Apr 29, 2025·0 cites·16 claims
- 1652US2021046177A1Compositions and methods for combination cancer vaccine and immunologic adjuvant therapyNANTCELL INC·Filed 2019·Application pending·0 cites
- 1744US2019022209A1Methods and compositions for influenza vaccinationETUBICS CORP·Filed 2017·Application pending·0 cites
- 1843US2019125852A1Compositions and methods for tumor vaccination using prostate cancer-associated antigensETUBICS CORP·Filed 2017·Application pending·0 cites
- 1943US2019134195A1Compositions and methods for the treatment of human papillomavirus (hpv)-associated diseasesETUBICS CORP·Filed 2017·Application pending·0 cites
- 2040US2019030151A1Methods and compositions for t-cell immunotherapyETUBICS CORP·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →